SEARCH

SEARCH BY CITATION

References

  • Adami C., Bianchi R., Pula G. and Donato R. (2004) S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta 1742, 169177.
  • Allen T. M. (1998) Liposomal drug formulation: rationale for development and what we can expect in the future. Drugs 56, 747756.
  • Bidwell G. L., 3rd and Raucher D. (2005) Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol. Cancer Ther. 4, 10761085.
  • Bidwell G. L., 3rd and Raucher D. (2010) Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv. Drug Deliv. Rev. 62, 14861496.
  • Bidwell G. L., 3rd, Davis A. N. and Raucher D. (2009) Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J. Control. Release 135, 210.
  • Bidwell G. L. 3rd, Whittom A. A., Thomas E., Lyons D., Hebert M. D. and Raucher D. (2010) A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation. Peptides 31, 834841.
  • Bidwell G. L., 3rd, Perkins E. and Raucher D. (2012) A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth. Cancer Lett. 319, 136143.
  • Bidwell G. L., 3rd, Perkins E., Hughes J., Khan M., James J. R. and Raucher D. (2013) Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS ONE 8, e55104.
  • Burright E. N., Clark H. B., Servadio A., Matilla T., Feddersen R. M., Yunis W. S., Duvick L. A., Zoghbi H. Y. and Orr H. T. (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937948.
  • Campbell C., Morimoto B. H., Nenciu D. and Fox A. W. (2012) Drug development of intranasally delivered peptides. Ther. Deliv. 3, 557568.
  • Charpentier T. H., Thompson L. E., Liriano M. A., Varney K. M., Wilder P. T., Pozharski E., Toth E. A. and Weber D. J. (2010) The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+  as examined by NMR and X-ray crystallography. J. Mol. Biol. 396, 12271243.
  • Chen H. K., Fernandez-Funez P., Acevedo S. F. et al. (2003) Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113, 457468.
  • Collins S. P. and Uhler M. D. (1997) Characterization of PKIgamma, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase. J. Biol. Chem. 272, 1816918178.
  • Demaille J. G., Peters K. A. and Fischer E. H. (1977) Isolation and properties of the rabbit skeletal muscle protein inhibitor of adenosine 3',5'-monophosphate dependent protein kinases. Biochemistry 16, 30803086.
  • Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C. and Giambanco I. (2009) S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 1793, 10081022.
  • Dreher M. R., Liu W., Michelich C. R., Dewhirst M. W. and Chilkoti A. (2007) Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res. 67, 44184424.
  • Emamian E. S., Kaytor M. D., Duvick L. A., Zu T., Tousey S. K., Zoghbi H. Y., Clark H. B. and Orr H. T. (2003) Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38, 375387.
  • Glass D. B., Feller M. J., Levin L. R. and Walsh D. A. (1992) Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. Biochemistry 31, 17281734.
  • Hanson L. R. and Frey W. H. 2nd (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 9 Suppl 3, S5.
  • Hearst S. M., Lopez M. E., Shao Q., Liu Y. and Vig P. J. (2010) Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation. J. Neurochem. 114, 706716.
  • Hearst S. M., Walker L. R., Shao Q., Lopez M., Raucher D. and Vig P. J. (2011) The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration. Neuroscience 197, 369380.
  • Jorgensen N. D., Andresen J. M., Lagalwar S. et al. (2009) Phosphorylation of ATXN1 at Ser776 in the cerebellum. J. Neurochem. 110, 675686.
  • Kissel M., Peschke P., Subr V., Ulbrich K., Schuhmacher J., Debus J. and Friedrich E. (2001) Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. PDA J. Pharm. Sci. Technol. 55, 191201.
  • Koeppen A. H. (2005) The pathogenesis of spinocerebellar ataxia. Cerebellum 4, 6273.
  • Liu W., Dreher M. R., Furgeson D. Y., Peixoto K. V., Yuan H., Zalutsky M. R. and Chilkoti A. (2006) Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J. Control. Release 116, 170178.
  • Liu Y., Buck D. C. and Neve K. A. (2008) Novel interaction of the dopamine D2 receptor and the Ca2+  binding protein S100B: role in D2 receptor function. Mol. Pharmacol. 74, 371378.
  • Massodi I., Thomas E. and Raucher D. (2009) Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules 14, 19992015.
  • Matilla-Duenas A., Goold R. and Giunti P (2008) Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1. Cerebellum 7, 106114.
  • McPherson D. T., Morrow C., Minehan D. S., Wu J., Hunter E. and Urry D. W. (1992) Production and purification of a recombinant elastomeric polypeptide, G-(VPGVG)19-VPGV, from Escherichia coli. Biotechnol. Prog. 8, 347352.
  • Meyer D. E. and Chilkoti A. (1999) Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat. Biotechnol. 17, 11121115.
  • Moktan S., Ryppa C., Kratz F. and Raucher D. (2012) A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis. Invest. New Drugs 30, 236248.
  • Neve K. A., Seamans J. K. and Trantham-Davidson H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165205.
  • Olsen S. R. and Uhler M. D. (1991) Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase. J. Biol. Chem. 266, 1115811162.
  • Ong S. R., Trabbic-Carlson K. A., Nettles D. L., Lim D. W., Chilkoti A. and Setton L. A. (2006) Epitope tagging for tracking elastin-like polypeptides. Biomaterials 27, 19301935.
  • Orr H. T. and Zoghbi H. Y. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575621.
  • Parfitt D. A., Michael G. J., Vermeulen E. G., Prodromou N. V., Webb T. R., Gallo J. M., Cheetham M. E., Nicoll W. S., Blatch G. L. and Chapple J. P. (2009) The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum. Mol. Genet. 18, 15561565.
  • Renner D. B., Svitak A. L., Gallus N. J., Ericson M. E., Frey W. H., 2nd and Hanson L. R. (2012) Intranasal delivery of insulin via the olfactory nerve pathway. J. Pharm. Pharmacol. 64, 17091714.
  • Rousselle C., Clair P., Lefauconnier J. M., Kaczorek M., Scherrmann J. M. and Temsamani J. (2000) New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57, 679686.
  • Sarantseva S. V., Bol'shakova O. I., Timoshenko S. I., Kolobov A. A., Vitek M. P. and Shvartsman A. L. (2009) Protein transduction domain peptide mediates delivery to the brain via the blood-brain barrier in Drosophila. Biomed. Khim. 55, 4149.
  • Seasholtz A. F., Gamm D. M., Ballestero R. P., Scarpetta M. A. and Uhler M. D. (1995) Differential expression of mRNAs for protein kinase inhibitor isoforms in mouse brain. Proc. Natl Acad. Sci. USA 92, 17341738.
  • Skinner P. J., Vierra-Green C. A., Clark H. B., Zoghbi H. Y. and Orr H. T. (2001) Altered trafficking of membrane proteins in purkinje cells of SCA1 transgenic mice. Am. J. Pathol. 159, 905913.
  • Sorci G., Bianchi R., Riuzzi F., Tubaro C., Arcuri C., Giambanco I. and Donato R. (2010) S100B Protein, a damage-associated molecular pattern protein in the brain and heart, and beyond. Cardiovasc. Psychiatry Neurol. doi: 10.1155/2010/656481. [epub ahead of print].
  • Southam D. S., Dolovich M., O'Byrne P. M. and Inman M. D. (2002) Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L833L839.
  • Urry D. W. (1992) Free energy transduction in polypeptides and proteins based on inverse temperature transitions. Prog. Biophys. Mol. Biol. 57, 2357.
  • Van Patten S. M., Howard P., Walsh D. A. and Maurer R. A. (1992) The alpha- and beta-isoforms of the inhibitor protein of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression. Mol. Endocrinol. 6, 21142122.
  • Vig P. J., Lopez M. E., Wei J., D'Souza D. R., Subramony S., Henegar J. and Fratkin J. D. (2006a) Glial S100B positive vacuoles in purkinje cells: earliest morphological abnormality in SCA1 transgenic mice. J. Neurol. Sci. Turk. 23, 166174.
  • Vig P. J., Subramony S. H., D'Souza D. R., Wei J. and Lopez M. E. (2006b) Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice. Brain Res. Bull. 69, 573579.
  • Vig P. J., Shao Q., Subramony S. H., Lopez M. E. and Safaya E. (2009) Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum 8, 231244.
  • Vig P. J., Hearst S., Shao Q., Lopez M. E., Murphy H. A., 2nd and Safaya E. (2011) Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Cerebellum 10, 254266.
  • Zheng L., Yu L., Tu Q., Zhang M., He H., Chen W., Gao J., Yu J., Wu Q. and Zhao S. (2000) Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA. Biochem. J. 349, 403407.